Company Valuation: T&R Biofab Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2023 2024 2025
Market Cap 1 192,208 93,405 179,277
Change - -51.4% 91.93%
Enterprise Value (EV) 1 186,483 122,186 200,979
Change - -34.48% 64.49%
P/E -14.1x -12.2x -3.91x
PBR 6.16x 3.86x 7.13x
PEG - 0.3x -0x
Capitalization / Revenue 37x 19.2x 6.65x
EV / Revenue 35.9x 25.1x 7.45x
EV / EBITDA -17.4x -11.2x -55.3x
EV / EBIT -14.5x -9.19x -23.2x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 -527.4 -297.1 -999.3
Distribution rate - - -
Net sales 1 5,199 4,874 26,967
EBITDA 1 -10,697 -10,895 -3,635
EBIT 1 -12,853 -13,299 -8,668
Net income 1 -13,419 -7,679 -31,951
Net Debt 1 -5,725 28,780 21,702
Reference price 2 7,441.67 3,612.50 3,910.00
Nbr of stocks (in thousands) 25,829 25,856 45,851
Announcement Date 3/17/25 3/17/25 3/18/26
1KRW in Million2KRW
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 72.57M
30.95x4.09x15.82x2.45% 181B
20.26x3.52x12.59x2.99% 116B
22.98x4.5x15.69x1.22% 113B
27.35x2.68x10.75x2.64% 79.83B
18.7x0.22x13.49x0.7% 65.06B
31.17x7.75x19.98x1.28% 54.35B
36.95x3.53x12.1x2.05% 52.23B
37.95x9.42x26.36x-.--% 44.15B
34.57x6.06x19.03x-.--% 32.47B
Average 28.99x 4.64x 16.20x 1.48% 73.87B
Weighted average by Cap. 27.60x 4.20x 15.35x 1.84%

Y-o-Y evolution of P/E

Valuation ratios - P/E - T&R Biofab Co., Ltd.

Historical PBR trend

Valuation ratios - PBR - T&R Biofab Co., Ltd.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - T&R Biofab Co., Ltd.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - T&R Biofab Co., Ltd.

  1. Stock Market
  2. Stocks
  3. A246710 Stock
  4. Valuation T&R Biofab Co., Ltd.